In December, the board had approved repurchasing $217 million of the company’s stock, or about 1.2 percent of the company’s outstanding shares.
In a news release, CEO Neal Patterson reiterated the repurchasing would be a good use of company funds, indicating he expects Cerner to continue the strong growth that characterized the company’s past two quarters.
“This program reflects our commitment to enhancing long-term shareholder value and our confidence in Cerner’s prospects as a leader in the growing healthcare industry,” said Mr. Patterson in the release.
More Articles on Cerner:
5 Takeaways From Cerner’s Annual Shareholders’ Meeting
7 Executives on Why They Selected Their Current EHR Vendor
4 Health IT Companies That Posted Increased Revenues in Q1
